These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25970639)

  • 41. [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
    Di Pasquale G; Riva L
    G Ital Cardiol (Rome); 2011 Sep; 12(9):556-65. PubMed ID: 21892216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.
    Blann AD; Boriani G; Lip GY
    Europace; 2016 Oct; 18(10):1507-1513. PubMed ID: 27876695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naïve, new-onset nonvalvular atrial fibrillation.
    Hurley C; Dai S; Sobieraj DM
    Int J Cardiol; 2015 Aug; 192():1-2. PubMed ID: 25981569
    [No Abstract]   [Full Text] [Related]  

  • 44. Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
    Jolobe OM
    Br J Hosp Med (Lond); 2017 Jul; 78(7):416. PubMed ID: 28692369
    [No Abstract]   [Full Text] [Related]  

  • 45. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Rost NS; Giugliano RP; Ruff CT; Murphy SA; Crompton AE; Norden AD; Silverman S; Singhal AB; Nicolau JC; SomaRaju B; Mercuri MF; Antman EM; Braunwald E;
    Stroke; 2016 Aug; 47(8):2075-82. PubMed ID: 27387994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).
    Link MS; Giugliano RP; Ruff CT; Scirica BM; Huikuri H; Oto A; Crompton AE; Murphy SA; Lanz H; Mercuri MF; Antman EM; Braunwald E;
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28077507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Another novel oral anticoagulant matches warfarin.
    Mitka M
    JAMA; 2014 Jan; 311(3):233-4. PubMed ID: 24430308
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.
    Marcy TR; Truong T; Rai A
    Consult Pharm; 2015 Nov; 30(11):644-56. PubMed ID: 26629800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of Patients With Atrial Fibrillation.
    Beaser AD; Cifu AS
    JAMA; 2019 Mar; 321(11):1100-1101. PubMed ID: 30874742
    [No Abstract]   [Full Text] [Related]  

  • 51. Terminated.
    Rosendaal FR; Reitsma PH
    J Thromb Haemost; 2014 Jun; 12(6):813. PubMed ID: 24916285
    [No Abstract]   [Full Text] [Related]  

  • 52. [New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
    Koziński M; Obońska K; Kubica A; Navarese EP; Kubica J
    Kardiol Pol; 2012; 70(10):1053-60. PubMed ID: 23080100
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of direct factor Xa inhibitors compared to warfarin in preventing stroke in adults with non-valvular atrial fibrillation: a systematic review protocol.
    Rasmussen KL; Hampton MD
    JBI Database System Rev Implement Rep; 2016 Jun; 14(6):69-77. PubMed ID: 27532651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.
    Masjuan J; DeFelipe A
    Int J Neurosci; 2017 Aug; 127(8):716-725. PubMed ID: 27586690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical trials and tribulations.
    Greaves M
    J Thromb Haemost; 2014 Jun; 12(6):822-3. PubMed ID: 24655890
    [No Abstract]   [Full Text] [Related]  

  • 56. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Piccini JP; Hellkamp AS; Washam JB; Becker RC; Breithardt G; Berkowitz SD; Halperin JL; Hankey GJ; Hacke W; Mahaffey KW; Nessel CC; Singer DE; Fox KA; Patel MR
    Circulation; 2016 Jul; 134(2):e7-8. PubMed ID: 27400902
    [No Abstract]   [Full Text] [Related]  

  • 57. Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Imprialos K; Boutari C; Stavropoulos K
    Circulation; 2016 Jul; 134(2):e5-6. PubMed ID: 27400901
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Bouatou Y; El Biali M; Samer CF
    Circulation; 2016 Jul; 134(2):e3-4. PubMed ID: 27400900
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US.
    Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M
    J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation.
    Oertel LB; Fogerty AE
    J Am Assoc Nurse Pract; 2017 Sep; 29(9):551-561. PubMed ID: 28805310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.